| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.38 | 0.03 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.0006 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.3 | 0.0006 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.28 | 0.002 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.25 | 0.004 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.005 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.23 | 0.008 |